Predictive validity of five comorbidity indices in prostate carcinoma patients treated with curative intent

Abstract

The better-performing, more comprehensive indices (CDS, ICED, and CIRS) would be useful in measuring and controlling for comorbidity in this setting. The CDS was easiest to apply and explained the most outcome variability.